We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Groupe Berkem SA | EU:ALKEM | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.08 | -3.36% | 2.30 | 2.30 | 2.44 | 2.39 | 2.28 | 2.39 | 16,049 | 16:40:00 |
From May 2024 to Jun 2024
Regulatory News:
Groupe Berkem (Paris:ALKEM):
Date
Number of shares outstanding
Total gross voting rights (1)
Total net voting rights(2)
April 30, 2024
17,767,652
29,837,901
29,782,564
(1) The total number of gross (or “theoretical”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.
(2) The total number of net (or “exercisable at a Shareholders’ Meeting”) voting rights is calculated without taking into account shares for which voting rights have been suspended. It is released in order to ensure that the public is properly informed, in accordance with the recommendation made by the AMF on 17 July 2007.
ABOUT GROUPE BERKEM
Founded in 1993 by Olivier Fahy, Chairman and Chief Executive Officer, Groupe Berkem is a leading force in the bio-based chemicals market. Its mission is to advance the environmental transition of companies producing the chemicals used in everyday lives (Construction & Materials, Health, Beauty & Nutrition, Hygiene & Protection, and Industry). By harnessing its expertise in both plant extraction and innovative formulations, Groupe Berkem has developed bio-based boosters—unique high-quality bio-based solutions augmenting the performance of synthetic molecules. Groupe Berkem achieved revenue of €51.9 million in 2023. The Group has almost 200 employees working at its head office (Blanquefort, Gironde) and 3 production facilities in Gardonne (Dordogne), La Teste-de-Buch (Gironde), Chartres (Eure-et-Loir) and Tonneins (Lot-et-Garonne).
Groupe Berkem has been listed on Euronext Growth Paris since December 2021 (ISIN: FR00140069V2 – ALKEM). www.groupeberkem.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240503745519/en/
Groupe Berkem Olivier Fahy, Chief Executive Officer Anthony Labrugnas, Chief Financial Officer Tel.: +33 (0)5 64 31 06 60 investisseurs@berkem.com
NewCap Investor Relations Mathilde Bohin / Nicolas Fossiez Tel.: +33 (0)1 44 71 94 94 Berkem@newcap.eu
NewCap Media Relations Nicolas Merigeau/ Antoine Pacquier Tel.: +33 (0)1 44 71 94 94 Berkem@newcap.eu
1 Year Groupe Berkem Chart |
1 Month Groupe Berkem Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
